SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

 

his rights or obligations hereunder to any person or entity without the express prior written consent of the Company, which consent may be granted or withheld by the Company in its sole discretion.

 

(g)        The Parties acknowledge and agree that RI is a third party beneficiary of this Agreement, as well as has certain obligations to the Company in this Agreement (See Section 6) inclusive of but not limited to Sections 4,5, and 6.

 

(h)       All notices and other communications hereunder shall be delivered or sent by commercial courier, facsimile, or registered or certified mail, return receipt requested, addressed to the party at the address herein set forth, or to such other address as such party may designate in writing to the other.

 

(i)           In the event that any provision of this Agreement shall be determined to be unenforceable by any court of competent jurisdiction by reason of its extending for too great a period of time or over too large a geographic area or over too great a range of activities, it shall be interpreted to extend only over the maximum period of time, geographic area or range of activities as to which it may be enforceable. If after application of the immediately preceding sentence, any provision of this Agreement shall be determined to be invalid, illegal or otherwise unenforceable by any court of competent jurisdiction, the validity, legality and enforceability of the other provisions of this Agreement shall not be affected thereby. Except as otherwise provided in this paragraph, any invalid, illegal or unenforceable provision of this Agreement shall be severable, and after any such severance, all other provisions hereof shall remain in full force and effect

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Consulting Agreement as of the date first set forth above.

 

 

BioLife Cell Bank Inc.

 

 

 

 

 

By:

/s/ John A. Carbona

 

Name: John A. Carbona

 

Title: Chief Executive Officer

 

 

 

Address:

11970 N. Central Expressway

 

 

Suite 260

 

 

Dallas, TX 75243

 

 

 

 

 

/s/ Brian K. Kaspar, Ph.D.

 

Brian K. Kaspar, Ph.D.

 

 

 

Address:

Research Institute at Nationwide

 

 

Children’s Hospital

 

 

700 Children’s Drive

 

 

Columbus, OH 43205

 

10



© AveXis, Inc. All Rights Reserved.